Biomerica, Inc. (BMRA)

Market Cap	5.46M
Revenue (ttm)	5.51M
Net Income (ttm)	-6.16M
Shares Out	16.82M
EPS (ttm)	-0.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,400
Open	0.320
Previous Close	0.320
Day's Range	0.300 - 0.330
52-Week Range	0.240 - 2.130
Beta	-1.14
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 14, 2025

About BMRA

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company’s diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist i...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 64
• Stock Exchange: NASDAQ
• Ticker Symbol: BMRA
• Website: https://www.biomerica.com

Financial Performance

In 2024, Biomerica's revenue was $5.42 million, an increase of 1.42% compared to the previous year's $5.34 million. Losses were -$5.98 million, -16.27% less than in 2023.